The following table sets forth certain information with respect to the beneficial ownership of the Company’s common stock as of May 27, 2005 by certain beneficial owners, each of the Company’s directors, certain executive officers and all executive officers and directors as a group.
ITEM 1. | APPROVAL OF THE ISSUANCE OF UP TO 2,857,565 SHARES OF OUR COMMON STOCK UPON THE EXERCISE OF CERTAIN SERIES B WARRANTS ISSUED BY THE COMPANY IN CONNECTION WITH A PRIVATE TRANSACTION CONSUMATED BY THE COMPANY |
After evaluating several opportunities during the third quarter of 2004 to obtain additional financing to provide us with working capital and increase the amount of our stockholders equity, in September 2004, we consummated a private placement with four institutional investors of $150 million of a new series of 6% Notes due 2014 (the “Notes”). In connection with the sale of the Notes, we entered into a Warrant Agreement pursuant to which we issued to these investors two series of warrants (the “Series A Warrants” and “Series B Warrants” and jointly, the “Warrants”) exercisable for an aggregate of 8,333,333 shares of our common stock. Of the $150 million in proceeds from the sale of the Notes and Warrants, we used $49 million to repurchase outstanding 7.35% notes due 2007 and 7.20% notes due 2007, which were held by the four investors. The remaining proceeds are being used for general corporate purposes, including the purchase of additional equipment, retirement of debt, potential acquisitions, and working capital.
We would receive gross cash proceeds of $150 million if all the outstanding Warrants were exercised for cash by the holders thereof. Any such proceeds would be used for general corporate purposes, including, but not limited to, the purchase of equipment, retirement of debt, acquisitions and/or working capital
Summary of Terms of Private Placement. The Warrants issued pursuant to the private placement are exercisable, at the option of the investors, into shares of our common stock at an exercise price of $18 per share. The exercise price and the number of shares issuable upon exercise of the Warrants will be subject to anti-dilution adjustments under certain circumstances as set forth in the Warrants and the Warrant Agreement. At the current exercise price of $18 per share, the Series A Warrants are exercisable for a total of 5,475,768 shares of common stock, and the Series B Warrants are exercisable for a total of 2,857,565 shares of common stock. The exercise of the Series A Warrants was not contingent upon stockholder approval, and all 5,475,768 Series A Warrants were exercisable immediately upon the completion of the private placement and are currently exercisable. The exercise of the Series B Warrants requires stockholder approval under the terms of the Series B Warrants. Accordingly, at this Special Meeting we are asking for stockholder approval for the issuance of common stock upon the exercise of the Series B Warrants.
If the Warrants were exercised in full, the common stock issuable upon the exercise of both the Series A and Series B Warrants (the “Warrant Shares”) would constitute 23.17% of our common stock outstanding as of May 27, 2005 (inclusive of the Warrant Shares). Issuance of common stock upon exercise of the Warrants would have a dilutive effect on the Company’s outstanding common stock and would reduce earnings per share for future periods.
In connection with the sale of the Notes and Warrants, certain of our significant stockholders, including our Chairman and Chief Executive Officer and a member of our Board of Directors and certain related stockholders, who collectively own more than 50% of our common stock, have entered into a voting agreement pursuant to which they have agreed to vote to approve the exercise of the Series B Warrants at this Special Meeting.
We have agreed to file a registration statement for the Warrant Shares and the Notes with the Securities and Exchange Commission by July 1, 2005. In addition, we have agreed to use commercially reasonable efforts to have the Warrant Shares registration statement and the Notes registration statement declared effective by September 1, 2005. It is impossible for us to predict when either of these registration statements will become effective. If either of these registration statements is not effective by October 1, 2005, or is not filed by July 1, 2005, we will be required to pay liquidated damages to the holders of these securities based upon a value of $150.0 million for the Notes and $150.0 million for the Warrants. For the first 90 days, the amount of liquidated damages to be paid related to the Warrants and the Notes will be calculated using a rate of 0.25% per annum for each day the registration statements are not effective after September 30, 2005 or if the registration statements are not filed by July 1, 2005. This percentage will be increased by 0.25% for each 90 day period, until these conditions are met, up to a maximum of 1.00% per annum.
Additional information about the sale of the Warrants appears in our Annual Report on Form 10-K for the year ended December 31, 2004, a copy of which (other than exhibits) is enclosed herewith. The form of the Warrant Agreement and the Series A and Series B Warrants are exhibits to that Form 10-K filing. Upon request, we will provide copies of these or any other exhibits to that Form 10-K filing at no cost to stockholders. All requests for copies should be directed to 211 College Road East, Princeton, New Jersey 08540, Attention of Investor Relations. xxxxx
Reasons for Stockholder Approval
Issuance or Potential Issuance of More of Our Outstanding Common Stock. The Company’s Board of Directors determined that the sale of the Notes and Warrants in September 2004 was advantageous to the Company and that the Warrant Shares to be issued upon exercise of the Warrants would further the best interests of the Company because the additional funds raised upon any exercise of the Warrants will provide additional operating capital for the Company. The Board considered the benefits and risks of raising funds based, in part, on estimated future market prices relative to other alternatives, and concluded that the terms set forth in the private placement in September 2004 were in the best interests of the Company and represented the best alternative available to the Company to meet its funding needs at the time. The Board of Directors therefore unanimously approved the sale of the Notes and Warrants and the issuance of shares of common stock upon exercise of the Warrants.
Impact of the Transaction. It is important to note that issuance of the Warrant Shares upon the exercise of the Warrants will result in dilution to the equity interests of other holders of the common stock. Specifically, upon receipt of stockholder approval of this proposal, the exercise of the Series B Warrants and the issuance of the additional common stock upon such exercise will result in a decrease of the relative voting control and dilute the equity interests of the holders of our common stock. However, our Directors, many of whom hold significant amounts of our common stock, recommend the approval of this proposal, as the issuance of shares of our common stock resulting from the exercise of the Warrants will increase the Company’s capital.
Under the terms of the Warrant Agreement, in the event that stockholder approval of the issuance of common stock pursuant to the Series B Warrants is not obtained at this Special Meeting, and if such approval is not otherwise obtained prior to June 30, 2005, the holders of the Series B Warrants will have the right, upon exercise of the Series B Warrants and payment of the applicable exercise price, to receive cash from the Company in an amount equal to 105% of the current market price of our common stock on the day prior to exercise.
Our stockholders will not have the opportunity to dissent from the transaction or to receive an agreed or judicially appraised value for their shares of common stock.
Vote Required and Recommendation of Board of Directors
We agreed with the investors that purchased our Notes and Warrants to use all commercially reasonable efforts to cause the holders of a majority of our outstanding shares of common stock, in accordance with all statutory laws and securities market or exchange rules applicable to the Company, to approve the exercise of the Series B Warrants. Our Board of Directors now solicits your proxy to be voted to approve the issuance of a sufficient number of shares of our common stock to be issued upon the exercise of the Series B Warrants.
The affirmative vote of a majority of the votes cast in person or by proxy at the meeting will be required to ratify and approve the issuance of common stock upon exercise of the Series B Warrants. Abstentions will not be counted toward the tabulation of votes cast on the proposal. Broker non-votes will be counted towards a quorum, but will not be counted for any purpose in determining whether this matter has been approved. Properly executed unrevoked proxies will be voted for Item 1 unless a vote against such proposal or an abstention is indicated.
THE BOARD OF DIRECTORS DEEMS THIS PROPOSAL TO BE IN THE BEST INTERESTS OF THE COMPANY AND RECOMMENDS A VOTE “FOR” THE APPROVAL OF THIS ITEM 1 RATIFYING THE POTENTIAL ISSUANCE OF UP TO 2,857,565 SHARES OF THE COMPANY’S COMMON STOCK IN CONNECTION WITH THE EXERCISE OF THE SERIES B WARRANTS.
SELECTED FINANCIAL DATA
(dollars in thousands, except share and per share amounts)
The following table sets forth our selected historical consolidated financial data for the periods and at the dates indicated. This information should be read in conjunction with our historical consolidated financial statements, and the notes thereto, included in our Annual Report on Form 10-K for the year ended December 31, 2004 and our Quarterly Report on Form 10-Q for the three month period ended March 31, 2005, both of which are incorporated by reference in this Proxy Statement. Copies of our Annual Report on Form 10-K for the year ended December 31, 2004 and our Quarterly Report on Form 10-Q for the three month period ended March 31, 2005 are enclosed with each copy of this proxy statement being mailed to stockholders.
SELECTED FINANACIAL DATA
(in thousands, except per share amounts)
(unaudited)
Three Months
YEAR ENDED DECEMBER 31, Ended March,
2004 2003(1)(2) 2002(1)(2)(3) 2001(1)(2)(4) 2000(1)(2)(4)(5) 31, 2005
---- ---------- ------------- ------------- ---------------- --------
INCOME STATEMENT DATA:
Equipment leasing revenue $388,183 $374,287 $325,080 $338,718 $287,553 $95,142
Depreciation and amortization
of leasing equipment $89,458 $87,498 $88,707 $79,678 $66,075 $21,933
Interest expense $112,013 $106,688 $108,344 $98,270 $87,809 $29,373
Fair value adjustment for
warrants $49,222 -- -- -- -- $(6,858)
Income before cumulative
effect of change in accounting
principle $8,429 $41,190 $4,389 $28,104 $44,040 $20,388
Income per share:
Basic $0.31 $1.51 $0.16 $1.03 $1.61 $0.74
===== ===== ===== ===== ===== =====
Diluted $0.29 $1.42 $0.15 $0.97 $1.61 $0.63
===== ===== ===== ===== ===== =====
Weighted average shares
outstanding:
Basic 27,380 27,365 27,360 27,417 27,421 27,638
Diluted 28,960 30,396 29,202 28,973 27,426 33,193
Cash dividends declared per
common share $0.25 $0.25 $0.2275 $0.1925 $0.15 $0.0625
2004 2003 2002 2001 2000 2005
---- ---- ---- ---- ---- ----
BALANCE SHEET DATA:
Cash and cash equivalents $309,458 $141,019 $170,613 $103,760 $157,224 $266,322
Net investment in direct $363,445 $426,815 $334,129 $275,372 $213,180 $370,627
financing leases
Leasing equipment, net $1,579,196 $1,636,716 $1,557,639 $1,335,610 $1,231,037 $1,643,470
Total assets $2,404,086 $2,373,036 $2,241,944 $1,923,052 $2,204,590 $2,428,844
Debt and capital lease $1,718,198 $1,715,687 $1,672,211 $1,429,680 $1,706,985 $1,686,419
obligations
Stockholders' equity $394,186 $383,640 $336,996 $352,072 $341,322 $418,029
(1) | As disclosed in our Quarterly Report on Form 10-Q for the nine months ended September 30, 2004, the Company uncovered an immaterial error related to financial statements not part of any current filing, which has been reported as an adjustment to opening retained earnings. For further information regarding this adjustment, see Note 1 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2004. |
(2) | Certain reclassifications have been made to the 2003, 2002, 2001 and 2000 amounts in order to conform to the 2004 presentation. |
(3) | Effective June 27, 2002, our financial statements include CAI as a consolidated subsidiary. (See Note 11 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2004.) |
(4) | As a result of adopting Statement of Financial Accounting Standards No. 145 ("SFAS 145") extraordinary gains related to the retirement of debt during the years ended December 31, 2001 and 2002, respectively, have been reclassified into operating income on a pretax basis. Income before cumulative effect of change in accounting principle include net of tax amounts of $558 and $840 for years ended December 31, 2001 and 2000, respectively. |
(5) | The 2000 income statement data excludes $660 resulting from the cumulative effect of change in accounting principle. The 2000 results include earnings from the assets acquired from Transamerica ("TA"), which we acquired on October 24, 2000, with an effective date of October 1, 2000. The 2000 results include only the chassis acquired from TA as the rail trailers and domestic containers were identified as assets held for sale at the time of purchase. |
PRO FORMA FINANCIAL INFORMATION
The following tables set forth selected pro forma financial information reflecting the sale of the Notes and Warrants. The pro forma condensed consolidated statements of income are presented as if the sale of the Notes and Warrants, the repurchase of $31.6 million of 7.35% notes due in 2007, and the repurchase of $17.5 million of 7.20% notes due in 2007, had occurred as of January 1, 2004. No pro forma balance sheet has been provided since our Balance Sheet at December 31, 2004, which has been incorporated by reference, includes the effect of the transactions described above. This pro forma information should be read in conjunction with the historical financial information provided above and with our historical consolidated financial statements, and the notes thereto, included in our Annual Report on Form 10-K for the year ended December 31, 2004 and our Quarterly Report on Form 10-Q for the three month period ended March 31, 2005, which are enclosed with the copies of this proxy statement sent to our stockholders. The pro forma financial information is not necessarily indicative of what our results of operations or financial condition would have been for the periods or at the dates indicated.
INTERPOOL, INC. AND SUBSIDIARIES
PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME
(dollars in thousands, except share and per share amounts)
(unaudited)
Year Ended December 31, 2004
Pro Forma
As Reported Adjustments Pro Forma
REVENUES:
Equipment leasing revenue $388,183 $--- $388,183
Other revenue 16,204 --- 16,204
------ --- ------
TOTAL REVENUES 404,387 --- 404,387
------- --- -------
COSTS AND EXPENSES:
Lease operating and administrative expenses 145,275 --- 145,275
Provision for doubtful accounts 1,476 --- 1,476
Fair value adjustment for derivative instruments (2,430) --- (2,430)
Fair value adjustment for warrants 49,222 --- 49,222
Depreciation and amortization of leasing equipment 89,458 --- 89,458
Impairment of leasing equipment 4,610 4,610
Income for investments accounted for under the equity method (416) --- (416)
Other income, net (15,686) --- (15,686)
Gain on insurance settlement (6,267) --- (6,267)
Interest expense 112,013 4,862 (a) 116,875
Interest income (3,390) --- (3,390)
------- --- -------
TOTAL COSTS AND EXPENSES 373,865 4,862 378,727
------- ----- -------
INCOME BEFORE MINORITY INTEREST EXPENSE AND PROVISION FOR INCOME TAXES 30,522 (4,862) 25,660
Minority interest expense, net (8,372) --- (8,372)
------- --- -------
Income before provision for income taxes 22,150 (4,862) 17,288
PROVISION FOR INCOME TAXES 13,721 (1,945) (b) 11,776
------ ------- ------
NET INCOME $8,429 $(2,917) $5,512
====== ======== ======
NET INCOME PER SHARE
Basic $0.31 $0.20
===== =====
Diluted (c) $0.29 $0.19
===== =====
WEIGHTED AVERAGE SHARES OUTSTANDING (in thousands)
Basic 27,380 27,380
====== ======
Diluted (c) 28,960 28,960
====== ======
(a) | Amount reflects the incremental interest expense incurred on the issuance of $150,000 of 6% notes, partially reduced by the interest expense savings on the repayment of $31,605 of 7.35% notes due in 2007 and $17,490 of 7.20% notes due in 2007 for the period from January 1 through September 14, 2004, the effective date of the transaction. |
(b) | Amount reflects the tax effect of the above items tax affected at 40% which represents a combined federal, state and local rate. |
(c) | The Warrants and the convertible redeemable subordinated debentures (with an exercise price in excess of the average market price for the year ended December 31, 2004) do not have a dilutive effect on income per share and therefore are not included in diluted income per share. |
As of the date of this proxy statement, we know of no business that will be presented for consideration at the Special Meeting other than the items referred to above. Proxies in the enclosed form will be voted in respect of any other business that is properly brought before the Special Meeting in accordance with the judgment of the person or persons voting the proxies.
OTHER INFORMATION
Copies of our Annual Report on Form 10-K for the year ended December 31, 2004 (other than exhibits) and our Quarterly Report on Form 10-Q for the three month period ended March 31, 2005 (other than exhibits) accompany this proxy statement and are incorporated by reference herein. Upon request, we will provide copies of any exhibits to these filings at no cost to stockholders. All requests for copies should be directed to 211 College Road East, Princeton, New Jersey 08540, Attention of Investor Relations.
Stockholders are invited to visit our internet website at www.interpool.com for information throughout the year and links to filings with the Securities and Exchange Commission.
A representative of our independent registered public accounting firm, KPMG LLP, is expected to be present at the Special Meeting with the opportunity to make a statement if such representative so desires and to respond to appropriate questions.
STOCKHOLDER PROPOSALS FOR THE 2005 ANNUAL MEETING
Any proposal of a stockholder intended to be presented at our 2005 Annual Meeting of Stockholders must be received by our Secretary by June 17, 2005 for inclusion in our proxy, notice of meeting and proxy statement relating to the 2005 Annual Meeting. Any proposals received after June 17, 2005 will be considered untimely.
By Order of the Board of Directors
| Martin Tuchman Chairman/Chief Executive Officer |
Preliminary Proxy Card
INTERPOOL, INC.
211 COLLEGE ROAD EAST
PRINCETON, NEW JERSEY 08540
PROXY – SPECIAL MEETING OF STOCKHOLDERS – ________, 2005
The undersigned hereby appoints Martin Tuchman and Arthur Burns as Proxies, each with the power to appoint his substitute, and hereby authorizes each of them to represent and to vote, all the shares of common stock of Interpool, Inc. held of record by the undersigned, on May 27, 2005, at the Special Meeting of Stockholders of INTERPOOL, INC. (the “Company”) to be held at the Union League Club, 38 East 37th Street, New York, New York 10016 (business attire required), on June 30, 2005, at 10:00 a.m., Eastern Time, or any adjournement thereof for the following purposes as designated on the reverse side hereof.
(Continued and to be signed on the Reverse Side)
(Reverse Side)
TO VOTE, MARK BLOCKS BELOW IN BLUE IPOOL1 KEEP THIS PORTION FOR
OR BLACK INK AS FOLLOWS: YOUR RECORDS
- ----------------------------------------------------------------------------------------------------
- DETACH AND RETURN THIS PORTION ONLY -
- ----------------------------------------------------------------------------------------------------
INTERPOOL, INC.
Vote on Proposal
FOR AGAINST ABSTAIN
1. Approval of the issuance of up to 2,857,565 shares of Interpool, [ ] [ ] [ ]
Inc. common stock upon the exercise of certain Series B Warrants
issued by the Company in connection with a private transaction
consummated by the Company.
YES NO
HOUSEHOLD ELECTION - Please indicate if you consent to receive certain [ ] [ ]
future investor communications in a single package per household
- ---------------------------------- ----------- ---------------------------------- -----------
- ---------------------------------- ----------- ---------------------------------- -----------
Signature [Please sign within box] Date Signature [Please sign within box] Date